Background: The prompt management of patients with bowel obstruction is essential and requires initial rapid diagnosis and therapeutic intervention. Therefore,
ONO-1301 has been developed as a novel long-acting prostacyclin agonist with thromboxane synthase inhibitory activity. In the present study, we investigated the